
 
 
 
 
 
 
 
 
   
 1. a kind of compound of following formula I: 
 
 
 
 And its salt and solvate, in which: 
 When between C2 and C3 there are when double bond, R 2 Selected from the group being made up of: 
 (ia)C 5-10 Aryl group, optionally by selected from include below group in one or more substituent groups replace: halogen, nitre
Base, cyano, ether, C 1-7 Alkyl, C 3-7 Heterocycle and double-oxygroup-C 1-3 Alkylidene； 
 (ib)C 1-5 Representative examples of saturated aliphatic alkyl； 
 (ic)C 3-6 Saturated cyclic alkyls； 
 (id) Wherein, R 11 、R 12 And R 13 Each of independently selected from H, C 1-3 Saturated alkyl, C 2-3 Alkenyl,
C 2-3 Alkynyl and cyclopropyl, wherein R 2 The sum of carbon atom is not more than 5 in group； 
 (ie) Wherein, R 15a And R 15b In one be H, and another is selected from: phenyl, and the phenyl can
Selection of land is replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl；With 
 (if) Wherein, R 14 It is selected from: H；C 1-3 Saturated alkyl；C 2-3 Alkenyl；C 2-3 Alkynyl；Cyclopropyl；Phenyl, institute
Phenyl is stated optionally to be replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl； 
 When between C2 and C3 there are when singly-bound, 
 R 2 It is Wherein, R 16a And R 16b Independently selected from H, F, C 1-4 Saturated alkyl, C 2-3 Alkenyl, the alkyl and
Alkenyl group is optionally selected from C 1-4 Alkyl amino and C 1-4 The group of Arrcostab replaces；Or work as R 16a And R 16b In one be H
When, another is selected from nitrile and C 1-4 Arrcostab； 
 As C2 ' and C3 ' between there are when double bond, R 12 Selected from the group being made up of: 
 (ia)C 5-10 Aryl group, optionally by selected from include below group in one or more substituent groups replace: halogen, nitre
Base, cyano, ether, carboxyl, ester, C 1-7 Alkyl, C 3-7 Heterocycle and double-oxygroup-C 1-3 Alkylidene； 
 (ib)C 1-5 Representative examples of saturated aliphatic alkyl； 
 (ic)C 3-6 Saturated cyclic alkyls； 
 (id) Wherein, R 21 、R 22 And R 23 Each of independently selected from H, C 1-3 Saturated alkyl, C 2-3 Alkenyl, C 2-3 
Alkynyl and cyclopropyl, wherein R 12 The sum of carbon atom is not more than 5 in group； 
 (ie) Wherein, R 25a And R 25b In one be H, and another is selected from: phenyl, and the phenyl is optional
Ground is replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl；With 
 (if) Wherein, R 24 It is selected from: H；C 1-3 Saturated alkyl；C 2-3 Alkenyl；C 2-3 Alkynyl；Cyclopropyl；Phenyl, it is described
Phenyl is optionally replaced by the group selected from halogen, methyl, methoxyl group；Pyridyl group；And thiophenyl； 
 As C2 ' and C3 ' between there are when singly-bound, 
 R 12 It is Wherein, R 26a And R 26b Independently selected from H, F, C 1-4 Saturated alkyl, C 2-3 Alkenyl, the alkyl and alkene
Base group is optionally selected from C 1-4 Alkyl amino and C 1-4 The group of Arrcostab replaces；Alternatively, working as R 26a And R 26b In one be H
When, another is selected from nitrile and C 1-4 Arrcostab； 
 R 6 And R 9 Independently selected from H, R, OH, OR, SH, SR, NH 2 , NHR, NRR ', nitro, Me 3 Sn and halogen； 
 Wherein, R and R ' is independently selected from optionally substituted C 1-12 Alkyl, C 3-20 Heterocycle and C 5-20 Aryl group； 
 R 7 Selected from H, R, OH, OR, SH, SR, NH 2 , NHR, NHRR ', nitro, Me 3 Sn and halogen； 
 R " is C 3-12 Alkylidene group, chain can be interrupted by item below one or more: hetero atom, such as O, S, NR N2 (its
In, R N2 It is H or C 1-4 Alkyl) and/or aromatic ring, such as benzene or pyridine； 
 Y and Y ' is selected from O, S or NH； 
 R 6’ 、R 7’ 、R 9’ Selected from respectively with R 6 、R 7 And R 9 Identical group； 
 R 20 It is H or Me and R 21a And R 21b All it is H or is formed together=O； 
 R L It is the connector for being connected to cell binding agent； 
 R 11b Selected from OH, OR A , wherein R A It is C 1-4 Alkyl and SO z M, wherein z is that 2 or 3 and M is monovalent medicinal cation. 
 
     
 
   
 
 2. compound according to claim 1, wherein R 7 It is C 1-4 Alkoxy base. 
 
     
 
   
   
 
 3. according to claim 1 or compound as claimed in claim 2, wherein Y is O, and R " is C 3-7 Alkylidene. 
 
     
 
   
   
   
 
 4. compound according to any one of claim 1 to 3, wherein R 6 And R 9 It is H. 
 
     
 
   
   
   
   
 
 5. compound according to any one of claim 1 to 4, wherein there are double bond between C2 ' and C3 ', and R 12 
It is: 
 (a)C 5-7 Aryl group, can have 1 to 3 substituent group group selected from the following: methoxyl group, ethyoxyl, fluorine, chlorine,
Cyano, double-oxygroup-methylene, methyl-piperazinyl group, morpholinyl and methyl-phenylsulfanyl；Or 
 (b) methyl, ethyl or propyl；Or 
 (c) cyclopropyl； 
 (d) group of following formula: Wherein, the R 12 The sum of carbon atom is not more than 4 in group；Or 
 (e) group: Or 
 (f) group of following formula: Wherein, R 24 Selected from H and methyl. 
 
     
 
   
   
   
   
 
 6. compound according to any one of claim 1 to 4, wherein there are singly-bound, R between C2 ' and C3 ' 12 It is And: 
 (a)R 26a And R 26b It is all H；Or 
 (b)R 26a And R 26b It is all methyl；Or 
 (c)R 26a And R 26b In one be H, and another be selected from C 1-4 Saturated alkyl, C 2-3 Alkenyl, the alkyl and alkenyl base
Group is optionally substituted. 
 
     
 
   
   
   
   
   
   
 
 7. compound according to any one of claim 1 to 6, wherein there are double bond between C2 and C3, and R 2 It is: 
 (a)C 5-7 Aryl group, can have 1 to 3 substituent group group selected from the following: methoxyl group, ethyoxyl, fluorine, chlorine,
Cyano, double-oxygroup-methylene, methyl-piperazinyl group, morpholinyl and methyl-phenylsulfanyl；Or 
 (b) methyl, ethyl or propyl；Or 
 (c) cyclopropyl；Or 
 (d) group of following formula: Wherein, the R 2 The sum of carbon atom is not more than 4 in group；Or 
 (e) Or 
 (f) Wherein, R 14 Selected from H and methyl. 
 
     
 
   
   
   
   
   
   
 
 8. compound according to any one of claim 1 to 6, wherein there are singly-bound, R between C2 and C3 2 It is And: 
 (a)R 16a And R 16b It is all H；Or 
 (b)R 16a And R 16b It is all methyl；Or 
 (c)R 16a And R 16b In one be H, and another be selected from C 1-4 Saturated alkyl, C 2-3 Alkenyl, the alkyl and alkenyl base
Group is optionally substituted. 
 
     
 
   
   
   
   
   
   
   
   
 
 9. compound according to any one of claim 1 to 8, wherein R 20 It is H or Me and R 21a And R 21b It is all H. 
 
     
 
   
   
   
   
   
   
   
   
 
 10. compound according to any one of claim 1 to 8, wherein R 20 It is H or Me and R 21a And R 21b Shape together
At=O. 
 
     
 
   
   
 
 11. according to claim 9 or compound described in any one of claim 10, wherein R 20 It is H. 
 
     
 
   
   
   
   
   
   
   
   
   
   
   
 
 12. compound according to any one of claim 1 to 11, wherein R 11b It is OH. 
 
     
 
   
   
   
   
   
   
   
   
   
   
   
 
 13. compound according to any one of claim 1 to 11, wherein R 11b It is OR A 。 
 
     
 
   
   
   
   
   
   
   
   
   
   
   
 
 14. compound according to any one of claim 1 to 11, wherein R 11b It is SO z M。 
 
     
 
   
 
 15. compound according to claim 14, wherein M is Na + And z is 3. 
 
     
 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
 
 16. according to claim 1 to compound described in any one of 15, for being used in the treatment of proliferative diseases. 
 
     
 17. a kind of conjugate, comprising be connected to target reagent according to claim 1 to the chemical combination of Formulas I described in any one of 15
Object or its pharmaceutical salts or solvate. 
 
     
 18. a kind of conjugate of formula IV: 
 L-(R L ’-D) p (IV), 
 Or its pharmaceutical salts or solvate, wherein L is with body unit, R L ' it is connector unit and D is following formula II: 
 
 
 
 Wherein, wave indicates R L’ Attachment point, and remaining group such as any one of claims 1 to 15 is defined. 
 
     
 
   
 
 19. conjugate according to claim 18, wherein L-R L’ It is following group: 
 
 
 
 Wherein, asterisk indicates the point for being attached to the position N10, and CBA is cell binding agent, L 1 It is the cleavable connector comprising dipeptides,
And dipeptides-NH-X 1 -X 2 Group-X in-CO- 1 -X 2 It is selected from: 
 -Phe-Lys-、 
 -Val-Ala-、 
 -Val-Lys-、 
 -Ala-Lys-、 
 -Val-Cit-、 
 -Phe-Cit-、 
 -Leu-Cit-、 
 -Ile-Cit-、 
 -Phe-Arg-、 
 - Trp-Cit-, 
 A is by L 1 It is connected to the linking group of the cell binding agent, L 2 Be covalent bond or with-OC (=O)-be formed together from point
The connector of solution. 
 
     
 
   
 
 20. conjugate according to claim 19, wherein C (=O) O and L 2 It is formed together following group: 
 
 
 
 Wherein, asterisk indicates the point for being attached to the position N10, and wave expression is attached to the connector L 1 Point, Y be NH, O,
C (=O) NH or C (=O) O, and n is 0 to 3. 
 
     
 
   
   
 
 21. according to claim 19 or claim 20 described in conjugate, wherein A is: 
 (i) 
 
 
 
 Wherein, asterisk expression is attached to L 1 Point, wave indicates to be attached to the point of the cell binding agent, and n is 0 to 6；
Or 
 (ii) 
 
 
 
 Wherein, asterisk expression is attached to L 1 Point, wave indicates to be attached to the point of the cell binding agent, and n is 0 or 1, and m
It is 0 to 30. 
 
     
 
   
   
   
   
 
 22. conjugate described in any one of 8 to 21 according to claim 1, wherein R 10 The cell binding agent be antibody or
Its active fragment. 
 
     
 
   
 
 23. conjugate according to claim 22, wherein the antibody or antibody fragment are for tumor associated antigen
Antibody or antibody fragment. 
 
     
 24. a kind of compound of formula A: 
 
 
 
 And its salt and solvate, wherein all substituent groups such as any one of claims 1 to 15 is defined. 
 
   
 
 
 
 
 
 
 
 
